Following its recent acquisition, Biosyn Ltd will change its name to Alere Health Ltd from April 1st 2010.

Alere is a Latin verb meaning to nurture, care for, or support. As a company focused on changing the future of healthcare to enable better patient outcomes, the name Alere Health well represents our goals.

Alere Health is the leading supplier of cardiovascular point of care testing products in Ireland. The company successfully launched the Triage™ Cardiac panel in 1999, followed two years later by Triage™ BNP - the world's leading biomarker for Congestive Heart Failure. Additionally with the Cholestech™ LDX Lipid Profile system, Alere Health is the market leader in cholesterol test kits for TC, HDL, LDL and Triglycerides, for screening and management of people with either known cardiovascular disease, or at risk of developing CHD.

Alere is focused on the development, manufacture and marketing of advanced consumer and professional medical diagnostic products. Through strategic acquisitions and the effective use of a vast intellectual property portfolio, the company now operates on a global scale providing locally relevant, world-class diagnostic tests and services to customers in the private and public.

Alere concentrates its efforts in five key areas: infectious diseases, cardiology, women's health, drugs of abuse and oncology. The organisation owns numerous patented technologies for both consumer and professional diagnostics, and offers an expanding range of products that includes brands such as Clearview, Testpack, Binax, Determine, and Biosite.

Further information can be found at www.alere.com